.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020577

« Back to Dashboard
NDA 020577 describes ELLIOTTS B SOLUTION, which is a drug marketed by Lukare Medical Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the ELLIOTTS B SOLUTION profile page.

The generic ingredient in ELLIOTTS B SOLUTION is calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate, dibasic, heptahydrate. There are two hundred and fifty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate, dibasic, heptahydrate profile page.

Suppliers and Packaging for NDA: 020577

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ELLIOTTS B SOLUTION
calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate, dibasic, heptahydrate
INJECTABLE;INTRATHECAL 020577 NDA Lukare Medical, LLC 55792-007 55792-007-10 10 AMPULE in 1 BOX (55792-007-10) > 10 mL in 1 AMPULE (55792-007-01)
ELLIOTTS B SOLUTION
calcium chloride; dextrose; magnesium sulfate; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate, dibasic, heptahydrate
INJECTABLE;INTRATHECAL 020577 NDA QOL Medical, LLC 67871-007 67871-007-10 10 AMPULE in 1 BOX (67871-007-10) > 10 mL in 1 AMPULE (67871-007-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRATHECALStrength0.2MG/ML;0.8MG/ML;0.3MG/ML;0.3MG/ML;1.9MG/ML;7.3MG/ML;0.2MG/ML
Approval Date:Sep 27, 1996TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc